Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3

Published:2019-09-18 Issue:1 Volume:7 Page:
ISSN:2051-1426
Container-title:Journal for ImmunoTherapy of Cancer
language:en
Short-container-title:j. immunotherapy cancer

Author:

Trovato Rosalinda,Fiore Alessandra,Sartori Sara,Canè Stefania,Giugno Rosalba,Cascione Luciano,Paiella Salvatore,Salvia Roberto,De Sanctis Francesco,Poffe Ornella,Anselmi Cristina,Hofer Francesca,Sartoris Silvia,Piro Geny,Carbone Carmine,Corbo Vincenzo^ORCID,Lawlor Rita,Solito Samantha,Pinton Laura,Mandruzzato Susanna,Bassi Claudio,Scarpa Aldo,Bronte Vincenzo,Ugel Stefano

Funder

Associazione Italiana per la Ricerca sul Cancro

Cancer reseacrh Institute

Euronanomed III

Cariverona Fondation

University of Verona

Qatar National Research Fund

Publisher

BMJ

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1186/s40425-019-0734-6.pdf

Reference59 articles.

1. Groot VP, et al. Patterns, timing, and predictors of recurrence following pancreatectomy for pancreatic ductal adenocarcinoma. Ann Surg. 2018;267(5):936–45.

2. Neoptolemos JP, et al. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Lancet. 2017;389(10073):1011–24.

3. Cid-Arregui A, Juarez V. Perspectives in the treatment of pancreatic adenocarcinoma. World J Gastroenterol. 2015;21(31):9297–316.

4. Incio J, et al. Obesity-induced inflammation and Desmoplasia promote pancreatic Cancer progression and resistance to chemotherapy. Cancer Discov. 2016;6(8):852–69.

5. Rielland M, et al. Senescence-associated SIN3B promotes inflammation and pancreatic cancer progression. J Clin Invest. 2014;124(5):2125–35.

Cited by 138 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of a Compound Inhibiting Both the Enzymatic and Nonenzymatic Functions of Indoleamine 2,3-Dioxygenase 1;ACS Pharmacology & Translational Science;2024-09-12

2. The Road Ahead in Pancreatic Cancer: Emerging Trends and Therapeutic Prospects;Biomedicines;2024-09-02

3. Epigenetic regulation of the tumor microenvironment: A leading force driving pancreatic cancer;Pancreatology;2024-09

4. Interferon regulatory factor 8-driven reprogramming of the immune microenvironment enhances antitumor adaptive immunity and reduces immunosuppression in murine glioblastoma;Neuro-Oncology;2024-08-08

5. Panoramic tumor microenvironment in pancreatic ductal adenocarcinoma;Cellular Oncology;2024-07-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3